2010
DOI: 10.1128/jvi.02634-09
|View full text |Cite
|
Sign up to set email alerts
|

Introduction of Virulence Markers in PB2 of Pandemic Swine-Origin Influenza Virus Does Not Result in Enhanced Virulence or Transmission

Abstract: In the first 6 months of the H1N1 swine-origin influenza virus (S-OIV) pandemic, the vast majority of infections were relatively mild. It has been postulated that mutations in the viral genome could result in more virulent viruses, leading to a more severe pandemic. Mutations E627K and D701N in the PB2 protein have previously been identified as determinants of avian and pandemic influenza virus virulence in mammals. These mutations were absent in S-OIVs detected early in the 2009 pandemic. Here, using reverse … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
116
0

Year Published

2010
2010
2014
2014

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 123 publications
(126 citation statements)
references
References 32 publications
10
116
0
Order By: Relevance
“…17,88,133 Surprisingly, the pandemic 2009 H1N1 virus, which was more virulent than most seasonal influenza viruses for humans and in experimental mammalian hosts, did not have the reputed virulence marker mutations in its PB2 protein. 45 When the molecular mutations in PB2 suggested to be virulence markers for avian viruses were introduced individually into the avianorigin PB2 of the pandemic 2009 H1N1 virus, virulence was not altered. 45 In summary, the polymerases appear to influence virulence through control of protein synthesis processes that favor virus production over cell maintenance functions, but sequence variations between polymerases will likely preclude identification of definitive virulence markers for all viruses.…”
Section: Polymerasesmentioning
confidence: 99%
“…17,88,133 Surprisingly, the pandemic 2009 H1N1 virus, which was more virulent than most seasonal influenza viruses for humans and in experimental mammalian hosts, did not have the reputed virulence marker mutations in its PB2 protein. 45 When the molecular mutations in PB2 suggested to be virulence markers for avian viruses were introduced individually into the avianorigin PB2 of the pandemic 2009 H1N1 virus, virulence was not altered. 45 In summary, the polymerases appear to influence virulence through control of protein synthesis processes that favor virus production over cell maintenance functions, but sequence variations between polymerases will likely preclude identification of definitive virulence markers for all viruses.…”
Section: Polymerasesmentioning
confidence: 99%
“…Sequence survey implied that the common host shift markers in the proteins of avian or swine influenza are not present in the pandemic 2009 H1N1 virus. Moreover, introduction of known virulence markers into 2009 H1N1 does not increase its virulence [26,27]. The combination of its pandemic potential and absence of traditional host markers has remained a source for concern and justifies the search for its own host markers outside of the space of classical host markers [28,29].…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, positions 627 and 701 in the viral polymerase basic 2 protein, residues shown to affect virulence in other influenza viruses, [57][58][59][60] had no effect in the context of the A(H1N1)pdm09 viruses. 47 In mice, some mutations are involved in A(H1N1)pdm09 virus virulence, such as polymerase basic 2 protein E158G/A, or polymerase acidic L295P. These mutations occurred upon serial passage in mice and were shown to be responsible for enhanced transcription and replication of the virus.…”
Section: Molecular Markers Of Virulencementioning
confidence: 99%
“…46 The introduction of molecular markers of virulence into the polymerase basic 2 protein were likewise unable to affect the transmissibility of A(H1N1)pdm09 viruses. 47 Ramakrishnan et al hypothesized that a truncated polymerase basic 1-F2 (PB1-F2) protein may play a role in enhancing the virus transmission, 48 but experimental validation of this theory is lacking.…”
mentioning
confidence: 99%